A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose
Clinical trial NCT06886269 · COMPLETED
Trial details
- NCT number
- NCT06886269
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-21
- Primary completion
- 2025-05-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.